158 related articles for article (PubMed ID: 3885960)
1. A longitudinal study of high and low avidity antibodies to double-stranded DNA in systemic lupus erythematosus.
McGrath H; Biundo JJ
Arthritis Rheum; 1985 Apr; 28(4):425-30. PubMed ID: 3885960
[TBL] [Abstract][Full Text] [Related]
2. Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance.
Nossent JC; Huysen V; Smeenk RJ; Swaak AJ
Ann Rheum Dis; 1989 Aug; 48(8):677-82. PubMed ID: 2789501
[TBL] [Abstract][Full Text] [Related]
3. Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity.
Smeenk RJ; Van Rooijen A; Swaak TJ
J Immunol Methods; 1988 Apr; 109(1):27-35. PubMed ID: 3282012
[TBL] [Abstract][Full Text] [Related]
4. Specificity in systemic lupus erythematosus of antibodies to double-stranded DNA measured with the polyethylene glycol precipitation assay.
Smeenk R; van der Lelij G; Swaak T; Groenwold J; Aarden L
Arthritis Rheum; 1982 Jun; 25(6):631-8. PubMed ID: 7092963
[TBL] [Abstract][Full Text] [Related]
5. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.
ter Borg EJ; Horst G; Hummel EJ; Limburg PC; Kallenberg CG
Arthritis Rheum; 1990 May; 33(5):634-43. PubMed ID: 2346519
[TBL] [Abstract][Full Text] [Related]
6. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA).
Swaak T; Smeenk R
Ann Rheum Dis; 1985 Apr; 44(4):245-51. PubMed ID: 3872637
[TBL] [Abstract][Full Text] [Related]
7. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
8. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
[TBL] [Abstract][Full Text] [Related]
9. Antibody avidity for native DNA in lupus nephritis.
Koyama A; Narita M; Tojo S
Contrib Nephrol; 1975; 4():72-82. PubMed ID: 1235100
[TBL] [Abstract][Full Text] [Related]
10. Detection of low avidity anti-DNA antibodies in systemic lupus erythematosus.
Riley RL; McGrath H; Taylor RP
Arthritis Rheum; 1979 Mar; 22(3):219-25. PubMed ID: 311203
[TBL] [Abstract][Full Text] [Related]
11. Low avidity antibodies to dsDNA as a diagnostic tool.
Nossent JC; Huysen V; Smeenk RJ; Swaak AJ
Ann Rheum Dis; 1989 Sep; 48(9):748-52. PubMed ID: 2802796
[TBL] [Abstract][Full Text] [Related]
12. High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns.
Matsuki Y; Suzuki K; Kawakami M; Ishizuka T; Kawaguchi Y; Hidaka T; Nakamura H
J Clin Apher; 1996; 11(1):30-5. PubMed ID: 8722720
[TBL] [Abstract][Full Text] [Related]
13. Stability of DNA/anti-DNA complexes. II. Salt lability and avidity.
Riley RL; Addis DJ; Taylor RP
J Immunol; 1980 Jan; 124(1):1-7. PubMed ID: 6985634
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus.
Bertouch JV; Roberts-Thompson PJ; Feng PH; Bradley J
Ann Rheum Dis; 1983 Dec; 42(6):655-8. PubMed ID: 6606401
[TBL] [Abstract][Full Text] [Related]
15. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
16. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.
Saisoong S; Eiam-Ong S; Hanvivatvong O
Clin Exp Rheumatol; 2006; 24(1):51-8. PubMed ID: 16539819
[TBL] [Abstract][Full Text] [Related]
17. The significance of serial measurement of serum anti-native DNA antibodies and complement C3 and C4 components in the management of patients with systemic lupus erythematosus.
Grennan DM; Moseley A; Sloane D; Pumphrey R; Dick WC; Buchanan WW
Aust N Z J Med; 1977 Dec; 7(6):625-9. PubMed ID: 306817
[TBL] [Abstract][Full Text] [Related]
18. The use of polyethylene glycol precipitation to detect low-avidity anti-DNA antibodies in systemic lupus erythematosus.
Smeenk R; Aarden L
J Immunol Methods; 1980; 39(1-2):165-80. PubMed ID: 7007509
[TBL] [Abstract][Full Text] [Related]
19. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
Lloyd W; Schur PH
Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
[TBL] [Abstract][Full Text] [Related]
20. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
